Mark M. Goodman, PhD


Radiology and Imaging Sciences, Psychiatry and Hematology and Oncology Tracer Development

Program Director

Emory Center for Systems Imaging and Director of the Radiopharmaceutical Discovery Lab

1841 Clifton Road NE

Atlanta, GA 30329

Phone: (404) 727-9366


Dr. Goodman is the Society of Nuclear Medicine (SNM) 2012 recipient of the prestigious Paul C. Aebersold Award for Outstanding Achievement in Basic Science applied to Nuclear Medicine. The award is named for Paul C. Aebersold, a pioneer in the biologic and medical application of radioactive materials. Dr. Goodman is also the 2010 recipient of The Welch Award, for his outstanding contribution to the field of radiopharmaceutical sciences.


  • Ph.D. Chemistry, University of Alabama, Alabama
  • B.A. Chemistry, Monmouth College, Illinois


  • University of Alabama Post-Doctoral Fellowship, 1976-1977
  • Yale University Post-Doctoral Fellowship, 1978
  • Harvard University Post-Doctoral Fellowship, 1978-1980

Research interests encompass radiotracer development of oncology, brain and heart agents. This includes non-natural amino acids for detection of tumors, cocaine analogs for in vivo study of the dopamine and serotonin reuptake sites in neurodegenerative, psychiatric and addictive disorders, heterocyclic analogs for in vivo mapping of CRF1, oxytocin and vassopressin receptors in psychiatric disorders and oligosaccahrides for imaging bacterial infections. Dr. Goodman translated the first [18F]amino acid, FACBC, for imaging intracranial tumors and prostate cancer in patients.